CLOV
Clover Health Investments Corp.
$3.53
+$0.06(+1.73%)
63
Overall
60
Value
66
Tech
--
Quality
Market Cap
$1.39B
Volume
7.27M
52W Range
$2.12 - $4.87
Target Price
$3.78
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $665.7M | $799.4M | $1.1B | $1.2B | $1.3B | ||
| Total Revenue | $672.9M | $1.5B | $3.5B | $1.3B | $1.4B | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $590.1M | $1.6B | $3.5B | $1.8B | $1.0B | ||
| GROSS PROFIT | |||||||
| Gross Profit | $82.8M | $-79.2M | $22.7M | $1.3B | $1.4B | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $765.6M | $2.1B | $394.4M | $1.5B | $1.4B | ||
| Research & Development | -- | -- | $3.5B | -- | -- | ||
| Selling, General & Administrative | $120.8M | $185.5M | $208.0M | $183.1M | $176.5M | ||
| General & Administrative Expenses | $120.8M | $185.5M | $208.0M | $183.1M | $176.5M | ||
| Salaries & Wages | $71.3M | $260.5M | $278.7M | $1.3B | $232.5M | ||
| Depreciation & Amortization | $21.7M | $15.0M | $1.2M | $2.5M | $1.3M | ||
| Depreciation & Amortization | $21.7M | $15.0M | $1.2M | $2.5M | $1.3M | ||
| Amortization | $21.1M | $13.7M | $30.0K | -- | -- | ||
| Securities Amortization | -- | $1.6B | -- | -- | -- | ||
| Other Operating Expenses | $12.5M | $-110.6M | $93.5M | -- | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $-92.7M | $-637.0M | $-371.6M | $-205.3M | $-45.7M | ||
| EBITDA | $-78.7M | $-569.6M | $-337.0M | $-207.9M | $-44.9M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $57.1M | $16.9M | $1.4M | $7.0K | -- | ||
| Intinc | $31.1M | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-36.0M | $-3.2M | $1.4M | $-7.0K | -- | ||
| Gain on Sale of Securities | $93.8M | $544.0K | $9.2M | $-4.7M | $-467.0K | ||
| Other Income/Expense | $-20.6M | $-738.7M | $33.4M | $-20.0M | $980.6M | ||
| Other Special Charges | $-73.1M | $738.7M | $2.4B | $24.7M | $26.2M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | $585.4M | $-876.3M | $-369.4M | $9.8M | $288.0K | ||
| Special Income Charges | $-585.4M | $876.3M | $-3.5B | $-25.8M | $-288.0K | ||
| Impairment of Capital Assets | -- | -- | $3.5B | $15.9M | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-79.3M | $-570.8M | $-338.2M | $-210.4M | $-46.3M | ||
| Pre-Tax Income | $-161.3M | $-366.5M | $-339.6M | $-217.4M | $-46.3M | ||
| INCOME TAX | |||||||
| Tax Provision | $-1.1M | $-365.0K | -- | $-231.0K | -- | ||
| NET INCOME | |||||||
| Net Income | $-136.4M | $-587.8M | $-339.6M | $-213.4M | $-43.0M | ||
| Net Income (Continuing Operations) | $-136.4M | $-587.8M | $-339.6M | $-210.1M | $-46.3M | ||
| Net Income (Discontinued Operations) | $-136.4M | $-587.8M | $-339.6M | $-213.4M | $-43.0M | ||
| Net Income (Common Stockholders) | $-136.4M | $-587.8M | $-339.6M | $-213.4M | $-43.0M | ||
| Normalized Income | -- | -- | -- | -- | $-45.5M | ||
| TOTALS | |||||||
| Total Expenses | $765.6M | $2.1B | $3.8B | $1.5B | $1.4B | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $130.1M | $412.9M | $476.2M | $482.2M | $490.0M | ||
| Average Shares Outstanding (Diluted) | -- | $412.9M | $476.2M | $482.2M | $490.0M | ||
| Shares Outstanding | $406.3M | $473.3M | $479.5M | $495.3M | $510.9M | ||
| Basic EPS | $-0.32 | $-1.42 | $-0.71 | $-0.44 | $-0.08 | ||
| Basic EPS (Continuing Operations) | $-0.32 | $-1.42 | $-0.71 | $-0.44 | $-0.09 | ||
| Diluted EPS | $-0.32 | $-1.42 | $-0.71 | $-0.44 | $-0.08 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.42 | $-0.71 | $-0.44 | $-0.09 | ||
| OTHER METRICS | |||||||
| Basic Discontinuous Operations | -- | -- | -- | -- | $0.01 | ||
| Development Expense | -- | -- | $3.5B | -- | -- | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | $0.01 | ||
| Interest Expense Operating | $-4.6M | $-1.7M | -- | -- | -- | ||
| Minority Interests | $3.9M | -- | $-3.9M | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | -- | $-3.2M | $3.3M | ||
| Net Income From Other Gains Losses | $117.3K | -- | -- | -- | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | $-3.2M | $3.3M | ||
| Other Gand A | $120.8M | $185.5M | $208.0M | $183.1M | $176.5M | ||
| Othspecchg | $28.3M | -- | -- | -- | -- | ||
| Restruct | $585.4M | $-876.3M | $-369.4M | $9.8M | $288.0K | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLOV | $3.53 | +1.7% | 7.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Clover Health Investments Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW